Want to see AU:GGR full AI Analyst Report?
GGR Stock Chart & Stats
AU$0.20
--
Market closed
AU$0.20
--
Day’s Range― - ―
52-Week RangeAU$0.10 - AU$0.33
Previous CloseN/A
VolumeN/A
Average Volume (3M)299.00K
Market Cap
AU$25.20M
Enterprise ValueAU$14.52M
Total Cash (Recent Filing)AU$6.44M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta0.27
Next Earnings
Apr 20, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding140,024,220
10 Day Avg. Volume126,568
30 Day Avg. Volume298,997
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)14.06
Price to Sales (P/S)0.00
P/FCF Ratio-30.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Modest LeverageSustained low-to-moderate debt reduces near-term refinancing and interest burden risks versus highly levered peers. For a loss-making company this structural cushion preserves optionality and gives management more time to pursue a turnaround or new revenue strategies without immediate solvency pressure.
Improving Cash Burn In 2025An improvement in free cash flow indicates progress on cost control or operational efficiency. While still negative, a durable reduction in cash burn lowers near-term financing needs, extends runway, and makes any restructuring or business redevelopment more feasible over the next several months.
Very Lean Operating StructureA minimal headcount implies a low fixed-cost base and a highly scalable cost structure, helping conserve cash and enabling rapid strategic pivots. Over a multi-month horizon, this lean profile reduces incremental cash requirements compared with larger peers and limits structural overhead risk.
Bears Say
Persistent Net Losses And Near-zero RevenueSustained losses combined with negligible revenue create a structural viability issue: without a clear revenue recovery, the company lacks the top-line base needed for scalable margins, making profitability dependent on either a material business change or continued external funding over the medium term.
Negative Operating And Free Cash FlowPersistent negative operating and free cash flow across multiple years means the business consumes cash rather than generates it, increasing reliance on external financing. Structurally, this erodes flexibility, risks dilution on future raises, and heightens survival risk absent a credible path to positive cash generation.
Eroding Equity And Deeply Negative ROEDeclining shareholders' equity and deeply negative ROE reflect ongoing value destruction and poor capital returns. Over time this weakens balance-sheet credibility, makes new capital more costly or dilutive, and signals structural problems in either business model or capital allocation that limit recovery prospects.
Reckon Health Care Holdings Ltd News
GGR FAQ
What was Reckon Health Care Holdings Ltd’s price range in the past 12 months?
Reckon Health Care Holdings Ltd lowest share price was AU$0.10 and its highest was AU$0.33 in the past 12 months.
What is Reckon Health Care Holdings Ltd’s market cap?
Reckon Health Care Holdings Ltd’s market cap is AU$25.20M.
When is Reckon Health Care Holdings Ltd’s upcoming earnings report date?
Reckon Health Care Holdings Ltd’s upcoming earnings report date is Apr 20, 2027 which is in 255 days.
How were Reckon Health Care Holdings Ltd’s earnings last quarter?
Currently, no data Available
Is Reckon Health Care Holdings Ltd overvalued?
According to Wall Street analysts Reckon Health Care Holdings Ltd’s price is currently Overvalued.
Does Reckon Health Care Holdings Ltd pay dividends?
Reckon Health Care Holdings Ltd does not currently pay dividends.
What is Reckon Health Care Holdings Ltd’s EPS estimate?
Reckon Health Care Holdings Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Reckon Health Care Holdings Ltd have?
Reckon Health Care Holdings Ltd has 140,024,220 shares outstanding.
What happened to Reckon Health Care Holdings Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Reckon Health Care Holdings Ltd?
Currently, no hedge funds are holding shares in AU:GGR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Reckon Health Care Holdings Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
291.32%
Trailing 12-Months
Company Description
Reckon Health Care Holdings Ltd
Golden Globe Resources Ltd. (GGR.AX) is an Australian mineral exploration company focused on discovering and developing copper and gold resources. The firm maintains full ownership of the Dooloo Creek Project, which includes two exploration permits spanning 77.94 square kilometers in Southeast Queensland. It also possesses an exploration license for minerals at the Neila Creek Prospect, covering 42.73 square kilometers in New South Wales. Incorporated in 2014 and based in Sydney, Australia, the company adopted its current name, Golden Globe Resources Ltd., in July 2017, having previously been known as Reckon Health Care Holdings Limited.